Morgan Lewis

For More Information

Read the Brochure

Read the FDA and Healthcare Practice brochure.

Fast Facts

LMG Life Sciences 2012 – Recommended for FDA – Pharmaceuticals and Healthcare: Pricing and Reimbursement

PLCCross-border Quarterly 2012 Life Sciences Legal Market Review

  • Industry Super League - Ranked 14th among law firms worldwide
  • Regulatory Super League - Ranked 8th among law firms worldwide

PLCCross-border Life Sciences Handbook 2007/2008

  • U.S. - Recognized for commercial/ partnering, competition/ antitrust, corporate, government law enforcement/ investigations, regulatory, regulatory/ medical devices, and patent counseling
  • England - Recognized for regulatory
  • Japan - Recognized for corporate/commercial

Chambers USA 2012: Washington, D.C. for healthcare/ pharmaceutical/medical products regulatory – Band 3

UK Legal 500 2007/2008: London: Pharmaceuticals and Biotechnology

New Resource

Healthcare Policy and Reform Resource Center

Related Events

05/04/14-05/07/14 MAGI's Clinical Research Conference - 2014 East
Gary Yingling, speaker, "FDA Inspections: Handling the Consequences"
05/27/14-05/29/14 UNL Fourth Governor’s Conference on Ensuring Food Safety Lincoln, Nebraska
Robert G. Hibbert, speaker
View all events

Related Publications

03/27/14 Medical Device Update: FDA Issues Proposed Regulations on Medical Device Classification and Reclassification to Streamline the Process
The Food and Drug Administration (FDA) issued proposed regulations on March 25, 2014 to implement Food and Drug Administration Safety and Innovation Act (FDASIA) provisions enacted in July 2012 on medical device classification and reclassification.
March 2014 FDA Draft Guidance Proposes Change to Combination Product Exclusivity Policy
New market exclusivity opportunities emerge for pharmaceutical companies.
View all publications

Related News

11/19/13 Pharmacists, Attorneys Question Whether Drug Compounding Bill Would Improve Safety, BNA's Daily Report for Executives
Although the drug industry generally supports the bill passed by the Senate Nov. 18, attorneys and some pharmacists question whether the bill really would improve the safety of compounded drugs.
10/03/13 Morgan Lewis Receives 2013 LMG Life Sciences Awards
Morgan Lewis was named Healthcare Pricing and Reimbursement Firm of the Year at the inaugural LMG Life Sciences awards ceremony.
09/27/13 Drug Comparison Suits May Drive Shift In Pharma Ads, Law360
Life Sciences partner Stephen Paul Mahinka is quoted.
View all news

Compliance Resources

New Resource: Health Industry Transparency Compliance Resource Center

Health Compliance Brochure

FDA Food Safety Modernization Act

Morgan Lewis understands the challenges facing the health industry in this era of increasing governmental regulation and enforcement. The pace of new regulations and statutes affecting regulatory obligations, reimbursement, and coverage creates new opportunities and challenges for manufacturers and suppliers, providers, payors, and patients. Health industry sectors are becoming increasingly interconnected and the laws governing them are closely linked. Providing effective and efficient legal services to the health industry requires integrated legal advice that addresses different regulatory structures and emerging industry developments.

Morgan Lewis has assembled a group of nationally recognized FDA and healthcare attorneys and professionals who take a collaborative and integrated approach to the representation of health industry clients in matters involving FDA, health regulatory, reimbursement, finance, policy, corporate, privacy/security, compliance, and government enforcement matters. On complex matters, our integrated approach gives clients peace of mind that their issues have been examined from every critical angle.